Boosting public health: how global pharmaceutical giants are transforming Malaysia's vaccine landscape / Choon Wai Yee

Multinational innovative pharmaceutical companies have been creating a lot of buzz lately in Malaysia's vaccine landscape, significantly contributing to public health by addressing vaccine-preventable diseases (VPDs). GlaxoSmithKline Pharmaceutical (GSK), a global biopharma company, is one of the key players in this effort. Through various initiatives, the company emphasises the importance of vaccinations as a foundation for building immunity, particularly in infants and young children.